COVID-19 ECHO Session #45: Leveraging on Existing HIV Community Engagement to Respond to COVID-19 Challenges and Opportunities
On 8 July 2021, this COVID-19 ECHO session was convened to discuss the perspective of Civil Society Organizations (CSOs) in leveraging on existing HIV community engagement to respo
June 2021 LabCoP Extended Echo Session: Implementation of the Lateral-Flow Urine Lipoarbinomannan Assay
On 30 June 2021 this Extended ECHO session was convened to discuss the implementation of the Lateral-Flow Urine Lipoarabinomannan (LF-LAM) assay for the detection of active tubercu
June 2021 LabCoP ECHO Session: Generating Demand for HIV Viral Load Testing Through Targeted Communications Campaigns
LabCoP’s June 2021 ECHO session focussed on generating demand for HIV viral load (VL) testing through targeted communications campaigns. WHO recommends at least one annual VL tes
LabCoP M&E Sub-CoP ECHO Session June 2021
In June the ASLM LabCoP monitoring and evaluation (M&E) Sub-CoP held an ECHO session on viral load (VL) testing data quality assessment. The presentation provided an overview o
May 2021 LabCoP Extended ECHO Session: The Global Fund COVID-19 Response Mechanism
On 12 May 2021, this Extended ECHO session was convened to discuss the Global Fund COVID-19 funding mechanism, an opportunity for countries to request funds to strengthen their hea
LabCoP M&E Sub-CoP ECHO Session May 2021
In May 2021 the ASLM LabCoP monitoring and evaluation (M&E) Sub-CoP held a session on data management, dashboards and connectivity solutions for HIV viral load (VL) and early i
COVID-19 ECHO Session #44: Country Experiences with the Use of Digital Tools for COVID-19
On 13 May 2021, this COVID-19 ECHO session was convened to discuss a series of case studies on country experiences regarding the design and implementation of digital tools to m
COVID-19 ECHO Session #43: Tuberculosis and the COVID-19 Pandemic: Tackling the challenge
On 29 April, 2021 this COVID-19 ECHO session was convened to discuss tuberculosis (TB) and the COVID-19 pandemic. This panel discussion session was moderated by Rinuka Garde, Senio
LabCoP M&E Sub-CoP ECHO Session Late April 2021
On 22 April 2021 ASLM’s LabCoP M&E Sub-community of practice held a south-to-south learning session during which the Uganda country team shared their experience in rolling ou
COVID-19 ECHO Session #42: Manufacturers of COVID-19 Diagnostic Products: Abbott and Beckman Coulter
On 15 April, 2021, ASLM’s LabCoP hosted the 13th session in a series about manufacturers of COVID-19 molecular diagnostic tools, featuring Abbott Rapid Diagnostics and Beckma